Pfizer and BioNTech propose expansion of pivotal Covid-19 vaccine trial

This article was originally published here

Enrollment in the trial has been proceeding as planned and the company expects to reach its initial target of up to 30,000 participants next week. The proposed expansion

The post Pfizer and BioNTech propose expansion of pivotal Covid-19 vaccine trial appeared first on Pharmaceutical Business review.